During the past decade, National Virus Reference Laboratory conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Virus Reference Laboratory" are "Crohn's Disease" (2 trials). Many other conditions were trialed in "National Virus Reference Laboratory" in a lesser frequency.

Most popular intervention types in "National Virus Reference Laboratory" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "PF-04236921" (1 trials) and "PF-04236921 SC injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Virus Reference Laboratory" are 2 trials for "All" genders.

Currently, there are NaN active trials in "National Virus Reference Laboratory". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in National Virus Reference Laboratory, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Virus Reference Laboratory, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".